35 related articles for article (PubMed ID: 12761489)
1. p53: the attractive tumor suppressor in the cancer research field.
Ozaki T; Nakagawara A
J Biomed Biotechnol; 2011; 2011():603925. PubMed ID: 21188172
[TBL] [Abstract][Full Text] [Related]
2. High expression of the evolutionarily conserved alpha/beta hydrolase domain containing 6 (ABHD6) in Ewing tumors.
Max D; Hesse M; Volkmer I; Staege MS
Cancer Sci; 2009 Dec; 100(12):2383-9. PubMed ID: 19793082
[TBL] [Abstract][Full Text] [Related]
3. Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy.
Pinca RS; Manara MC; Chiadini V; Picci P; Zucchini C; Scotlandi K
Oncol Rep; 2017 Mar; 37(3):1387-1393. PubMed ID: 28112365
[TBL] [Abstract][Full Text] [Related]
4. The importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy.
Rello-Varona S; Herrero-Martín D; Lagares-Tena L; López-Alemany R; Mulet-Margalef N; Huertas-Martínez J; Garcia-Monclús S; García Del Muro X; Muñoz-Pinedo C; Tirado OM
Front Oncol; 2015; 5():82. PubMed ID: 25905041
[TBL] [Abstract][Full Text] [Related]
5. Variability in functional p53 reactivation by PRIMA-1(Met)/APR-246 in Ewing sarcoma.
Aryee DN; Niedan S; Ban J; Schwentner R; Muehlbacher K; Kauer M; Kofler R; Kovar H
Br J Cancer; 2013 Nov; 109(10):2696-704. PubMed ID: 24129240
[TBL] [Abstract][Full Text] [Related]
6. Amyloid precursor-like protein 2 suppresses irradiation-induced apoptosis in Ewing sarcoma cells and is elevated in immune-evasive Ewing sarcoma cells.
Peters HL; Yan Y; Nordgren TM; Cutucache CE; Joshi SS; Solheim JC
Cancer Biol Ther; 2013 Aug; 14(8):752-60. PubMed ID: 23792571
[TBL] [Abstract][Full Text] [Related]
7. Targeting the p53 Pathway in Ewing Sarcoma.
Neilsen PM; Pishas KI; Callen DF; Thomas DM
Sarcoma; 2011; 2011():746939. PubMed ID: 21197471
[TBL] [Abstract][Full Text] [Related]
8. Cell Cycle Deregulation in Ewing's Sarcoma Pathogenesis.
Kowalewski AA; Randall RL; Lessnick SL
Sarcoma; 2011; 2011():598704. PubMed ID: 21052502
[TBL] [Abstract][Full Text] [Related]
9. EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma.
Ban J; Bennani-Baiti IM; Kauer M; Schaefer KL; Poremba C; Jug G; Schwentner R; Smrzka O; Muehlbacher K; Aryee DN; Kovar H
Cancer Res; 2008 Sep; 68(17):7100-9. PubMed ID: 18757425
[TBL] [Abstract][Full Text] [Related]
10. Tissue microarrays: applications in study of p16 and p53 alterations in Ewing's cell lines.
Noguera R; Machado I; Piqueras M; Lopez-Guerrero JA; Navarro S; Mayordomo E; Pellin A; Llombart-Bosch A
Diagn Pathol; 2008 Jul; 3 Suppl 1(Suppl 1):S27. PubMed ID: 18673516
[TBL] [Abstract][Full Text] [Related]
11. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Crowe DL; Sinha UK
Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
[TBL] [Abstract][Full Text] [Related]
12. The role of the p53 protein in the apoptotic response.
Lane DP; Lu X; Hupp T; Hall PA
Philos Trans R Soc Lond B Biol Sci; 1994 Aug; 345(1313):277-80. PubMed ID: 7846126
[TBL] [Abstract][Full Text] [Related]
13. Relationship of p53 to the control of apoptotic cell death.
Oren M
Semin Cancer Biol; 1994 Jun; 5(3):221-7. PubMed ID: 7948950
[TBL] [Abstract][Full Text] [Related]
14. Response of Ewing tumor cells to forced and activated p53 expression.
Kovar H; Pospisilova S; Jug G; Printz D; Gadner H
Oncogene; 2003 May; 22(21):3193-204. PubMed ID: 12761489
[TBL] [Abstract][Full Text] [Related]
15. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines.
Concin N; Stimpfl M; Zeillinger C; Wolff U; Hefler L; Sedlak J; Leodolter S; Zeillinger R
Int J Oncol; 2003 Jan; 22(1):51-7. PubMed ID: 12469184
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic profile of biomarkers related to anti-apoptotic and neural development pathways in the Ewing's family of tumors (EFT) and their therapeutic implications.
Navarro S; Giraudo P; Karseladze AI; Smirnov A; Petrovichev N; Savelov N; Alvarado-Cabrero I; Llombart-Bosch A
Anticancer Res; 2007; 27(4B):2457-63. PubMed ID: 17695539
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
